The Senior Corporate Counsel, Commercial provides legal support for the launch of a gene editing therapy, advising on regulatory compliance, strategic initiatives, and enhancing Intellia's compliance program.

Lead market access strategy and value communication for Intellia's gene editing therapies, focusing on ATTR. Develop strategies, foster stakeholder communication, and ensure launch readiness.

The Director will oversee insights generation, analytics, and forecasting for Intellia's ATTR therapy, collaborating cross-functionally to support commercialization efforts and strategic planning.

The Principal CMC Data Scientist will lead data science efforts in CMC by applying statistical methodologies, managing projects, and supporting the pharmaceutical development lifecycle, particularly in CPV.

The National Account Director will lead the market access strategy for gene editing therapies, managing relationships with insurers and developing coverage plans, while collaborating across internal teams to ensure successful product launches.

The Senior Director, Field HEOR will shape and execute market access strategies for gene editing therapies, focusing on payer engagements, evidence generation, and strategic insights for favorable reimbursement decisions.

The Associate Director will support pricing, contracting, and market access strategies for CRISPR therapies, focusing on operational activities, contract management, and revenue operations in a collaborative environment.

Lead R&D Quality Assurance strategy for clinical studies. Oversee compliance with regulations and collaborate cross-functionally to drive quality and risk management initiatives.

Lead a team of Strategic Account Managers to activate treatment sites and ensure the procurement and administration of CRISPR therapies. Drive strategy, cross-functional collaboration, and operational excellence while building relationships with key stakeholders in healthcare.

The Senior Director, ATTR Global Brand Lead will shape the global brand strategy for nexiguran ziclumeran, driving commercialization through leadership and collaboration with cross-functional teams.

Lead and develop a team of Strategic Account Managers to activate treatment sites for CRISPR therapy, ensure procurement and delivery, manage cross-functional collaboration, and maintain high performance standards in patient access to therapies.